| Literature DB >> 10985143 |
Abstract
Since its inception in 1969, the NWTSG has performed successful studies that are now the model for the management of pediatric malignancies. Future studies may use genetic markers to stratify high-risk patients beyond the traditional staging system. Therapy will continue to be evaluated to determine the minimal therapy necessary to achieve the best outcome for children with Wilms' tumor.Entities:
Mesh:
Year: 2000 PMID: 10985143 DOI: 10.1016/s0094-0143(05)70091-4
Source DB: PubMed Journal: Urol Clin North Am ISSN: 0094-0143 Impact factor: 2.241